Haematological determinants of cardiac involvement in adults with sickle cell disease
The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
AIMS: Cardiac involvement is common in sickle cell disease (SCD). Studies are needed to establish haematological determinants of this involvement and prognostic markers. The aim of the study was to identify haematological factors associated with cardiac involvement in SCD and their impact on prognosis. METHODS AND RESULTS: This longitudinal observational study was performed on 1780 SCD patients with SS or S-β(0)-thalassemia referred to our centre. Six hundred fifty-six met our inclusion criteria (availability of a blood-workup and echocardiogram obtained <1 year apart, no heart valve surgery and no current pregnancy). Median age was 31 (interquartile range, 25-40) years, and median haemoglobin (Hb) was 87 (80-95)g/L. Left ventricular (LV) dilation, left atrial dilation, cardiac index (CI) >4 L/min/m(2), LV ejection fraction <55%, and tricuspid regurgitant velocity (TRV) ≥2.5 m/s were found in 35, 78, 23, 8.5, and 17% of patients, respectively. Compared with other patients, those in the fourth quartiles (Q4) of LV end-diastolic dimension index (LVEDDind) and left atrial dimension index (LADind) and those with high CI had significantly lower Hb, % foetal Hb (HbF), and red blood cell (RBC) counts; and significantly higher lactate dehydrogenase, bilirubin, and %dense RBCs. Independent haematologic determinants of Q4 LVEDDind and LADind were low RBC count and %HbF; high %dense RBCs were associated with LADind. Low %HbF and RBC count were associated with high CI. High %dense RBCs or no α-thalassemia gene deletion was associated with greater severity of anaemia and cardiac dilation and with higher CI. During the median follow-up of 48 (32-59) months, 50 (7.6%) patients died. Tricuspid regurgitant velocity ≥ 2.5 m/s was a predictor of mortality. The risk of death increased four-fold when left ventricular ejection fraction <55% was present also (P = 0.0001). CONCLUSION: Cardiac dilation and CI elevation in patients with SCD are associated with haematologic variables reflecting haemolysis, RBC rigidity, and blood viscosity. Tricuspid regurgitant velocity ≥ 2.5 and LV dysfunction (even mild) predict mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another large population screening study confirmed that a tricuspid regurgitant jet velocity ≥2.5 m/s was associated with a hazard ratio of 6.81 in multivariate analysis and rose linearly above this value (50% of death at tricuspid regurgitant jet velocity of 3.2 m/s) (192).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [192]
Citations
Cites
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Pain in Sickle Cell Disease: Rates and Risk Factors
Platt, O. S., Thorington, B. D., Brambilla, D. J., Milner, P. F., Rosse, W. F., Vichinsky, E., & Kinney, T. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107043250103 · Cited by 1,546 · cited 1×
“Our finding that %HbF was associated with LVEDDind, LADind, CI, and TRV is consistent with the ability of HbF to limit HbS polymerization and thus sickling and to improve RBC properties.(24,25) This protective effect contrasts with the hypothesis that increased level of HbF leads to a lower tissue oxygen delivery due…”
ResultPulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Pathogenesis and Treatment of Sickle Cell Disease
Bunn, H. F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371107 · Cited by 1,154 · cited 1×
“Our finding that %HbF was associated with LVEDDind, LADind, CI, and TRV is consistent with the ability of HbF to limit HbS polymerization and thus sickling and to improve RBC properties.(24,25) This protective effect contrasts with the hypothesis that increased level of HbF leads to a lower tissue oxygen delivery due…”
ResultMorris, C. R. (2005) · JAMA · doi:10.1001/jama.294.1.81 · Cited by 763
A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease
Parent, F., Bachir, D., Inamo, J., Lionnet, F., Driss, F., Loko, G., Habibi, A., Bennani, S., Savale, L., Adnot, S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1005565 · Cited by 512
Self-citationCardiovascular effects of anemia
Varat, M. A., Adolph, R. J., & Fowler, N. O. (1972) · American Heart Journal · doi:10.1016/0002-8703(72)90445-0 · Cited by 429
DETERMINATION OF DENSITY DISTRIBUTION OF RED CELL POPULATION.
Danon, D., & Marikovsky (1964) · PubMed · Cited by 376
Diastolic Dysfunction Is an Independent Risk Factor for Death in Patients With Sickle Cell Disease
Sachdev, V., Machado, R. F., Shizukuda, Y., Rao, Y. N., Sidenko, S., Ernst, I., St. Peter, M., Coles, W. A., Rosing, D. R., Blackwelder, W. C., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.038 · Cited by 323
Cited by
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Intravascular hemolysis and the pathophysiology of sickle cell disease
Kato, G. J., Steinberg, M. H., & Gladwin, M. T. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89741 · Cited by 748
Liem, R. I., Lanzkron, S., D. Coates, T., DeCastro, L., Desai, A. A., Ataga, K. I., Cohen, R. T., Haynes, J., Osunkwo, I., Lebensburger, J. D., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000916 · Cited by 182
Maitra, P., Caughey, M., Robinson, L., Desai, P. C., Jones, S., Nouraie, M., Gladwin, M. T., Hinderliter, A., Cai, J., & Ataga, K. I. (2017) · Haematologica · doi:10.3324/haematol.2016.153791 · Cited by 137
Cardiovascular complications of sickle cell disease
Sachdev, V., Rosing, D. R., & Thein, S. L. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2020.02.002 · Cited by 92
Metadata
- Authors
- Damy, T., Bodez, D., Habibi, A., Guellich, A., Rappeneau, S., Inamo, J., Guendouz, S., Gellen-Dautremer, J., Pissard, S., Loric, S., Wagner-Ballon, O., Godeau, B., Adnot, S., Dubois-Randé, J.-L., Hittinger, L., Galactéros, F., & Bartolucci, P.
- Affiliations
- Inserm (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Centre Hospitalier Universitaire de Martinique (MQ)
- Centre Hospitalier Universitaire Henri-Mondor (FR)
- Université Paris-Est Créteil (FR)
- Corresponding author
- Damy, Thibaud
- ORCID
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-10-29
- Volume
- 37
- Issue
- 14
- Pages
- 1158-1167
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W1888504096
- Cited by
- 65
- References
- 51
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 6 · 2023: 7 · 2022: 4 · 2021: 3 · 2020: 3 · 2019: 10 · 2018: 7 · 2017: 10 · 2016: 5
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- AREMCAR (Association pour la Recherche et l'Etude des Maladies Cardiovasculaires), a non-profit organization
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Keywords
- sickle cell disease, cardiac involvement, left ventricular dilatation, left atrial enlargement, cardiac index, fetal hemoglobin, red blood cell count, tricuspid regurgitation, left ventricular ejection fraction, prognosis, mortality, alpha-thalassemia, anemia severity, echocardiography, hemoglobin
- MeSH terms
- Adult, Anemia, Sickle Cell, Cardiomyopathy, Dilated, Echocardiography, Erythrocyte Count, Erythrocytes, Female, Heart Diseases, Humans, Longitudinal Studies, Male, Risk Factors, Stroke Volume, Tricuspid Valve Insufficiency, beta-Thalassemia, Ventricular Dysfunction, Left, Ventricular Remodeling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Haematological determinants of cardiac involvement in adults with sickle cell disease. https://app.cochat.ai/papers/10.1093/eurheartj/ehv555
- The paper
- Damy, T., Bodez, D., Habibi, A., Guellich, A., Rappeneau, S., Inamo, J., Guendouz, S., Gellen-Dautremer, J., Pissard, S., Loric, S., Wagner-Ballon, O., Godeau, B., Adnot, S., Dubois-Randé, J.-L., Hittinger, L., Galactéros, F., & Bartolucci, P. (2016). Haematological determinants of cardiac involvement in adults with sickle cell disease. European Heart Journal. https://doi.org/10.1093/eurheartj/ehv555
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.